pentobarbital decreases levels of vandetanib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Stay clear of coadministration with strong CYP3A4 inducers; these prescription drugs minimize publicity to vandetanib by as much as 40%.IM injection from the sodium salts of barbiturates must be designed deeply into a substantia